Advancements in Isoniazid-Based Heterocyclic Derivatives as Potent Antitubercular Agents: A Comprehensive Review of Synthesis, SAR, and Biological Activity (2017–2023)

Abstract

Tuberculosis (TB) continues to be a major health problem worldwide, requiring the development of new and innovative therapeutic agents. Isoniazid (INH) is one of the drugs of choice for treating tuberculosis. It is activated by KatG, which produces nicotinamide adenine dinucleotide (NAD). The resulting metabolites inhibit enoyl-acyl carrier protein (ACP) reductase (InhA), an enzyme involved in the biosynthesis of mycolic acid in Mycobacterium tuberculosis. This inhibition disrupts the production of type II fatty acids, which are essential for mycolic acid synthesis and cell survival. However, INH-resistant mycobacterial strains are becoming more prevalent, primarily due to long-term, widespread use and misuse. Researchers have extensively researched and modified INH, a cornerstone in TB treatment, to improve its efficacy and reduce resistance. Numerous investigations have shown that heterocyclic scaffolds, when coupled with INH, exhibit excellent antitubercular activity by increasing the permeation of the drug into bacterial cells. The review highlights various heterocyclic moieties, including phenylisoxazole, indanyl, indole, and isatin, emphasizing their role in improving pharmacokinetic properties and overcoming drug resistance. Here, we have focused on INH-clubbed heterocyclic derivatives that were investigated from 2018 to 2023 as potential antitubercular agents. This review aims to guide future research and development of INH-based heterocyclic derivatives, offering a valuable resource for researchers in the quest for more effective antitubercular therapies.

1 Introduction

2 Challenges with Current Drug Treatment

3 Literature Reports on INH-Clubbed Heterocyclic Derivatives

4 Conclusion

5 Abbreviations

Key words

isoniazid - heterocycles - antituberculosis - drug resistance

Publikationsverlauf

Eingereicht: 30. November 2024

Angenommen nach Revision: 03. Februar 2025

Accepted Manuscript online:
03. Februar 2025

Artikel online veröffentlicht:
16. Mai 2025

• References

• 1 Yadav K, Prakash S. Int. J. Microbiol. 2017; 5: 225
• 2 Mohajan H. mpra.ub.uni-muenchen.de 2014; 3: 18
• 3 Kumar M, Kumar P, Chandra V, Choudhary MK, Verma NK. Int. J. Health Sci. 2022; 6: 11876
• 4 Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwab P, Glaziou P, Zumla A. Lancet Infect. Dis. 2013; 13: 436
• 5 Ndong Sima CA. A, Smith D, Petersen DC, Schurz H, Uren C, Möller M. Immunogenetics 2023; 75: 215
• 6 Bagcchi S. The Lancet Microbe 2022; 4: e20
• 7 Al Abri S, Kasaeva T, Migliori GB, Goletti D, Zenner D, Denholm J, Petersen E. Int. J. Infect. Dis. 2020; 92: S60
• 8 Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Weyer K. J. Infect. Dis. 2007; 196: S86
• 9 Eldholm V, Rieux A, Monteserin J, Lopez JM, Palmero D, Lopez B, Balloux F. Elife 2016; 5: e16644
• 10 Park M, Tang JH, Bradley EH, Webster TR, Schlesinger M, Baker D, Inouye SK. Qual. Saf. Health Care 2006; 15: 334
• 11 Ahmad S, Mokaddas E. J. Infect. Public Health 2014; 7: 75
• 12 Falzon D, Gandhi N, Migliori GB, Sotgiu G, Cox HS, Holtz TH, Menzies D. Eur. Respir. J. 2013; 42: 156
• 13 Jassal M, Bishai WR. A. Lancet Infect. Dis. 2009; 9: 19
• 14 Blumberg HM, Ernst JD. JAMA 2016; 316: 931
• 15 Kiazyk S, Ball TB. Can. Commun. Dis. Rep. 2017; 43: 62
• 16 Eldehna WM, Fares M, Abdel-Aziz MM, Abdel-Aziz HA. Molecules 2015; 20: 8800
• 17 Unissa AN, Subbian S, Hanna LE, Selvakumar N. Infect. Genet. Evol. 2016; 45: 474
• 18 Grobbelaar M, Louw GE, Sampson SL, van Helden PD, Donald PR, Warren RM. Infect., Genet. Evol. 2019; 74: 103937
• 19 Zhang Y, Shi W, Zhang W, Mitchison D. Microbiol. Spect. 2014; 2: 10.1128
• 20 Zhu C, Liu Y, Hu L, Yang M, He ZG. J. Biol. Chem. 2018; 293: 16741
• 21 Thee S, Garcia-Prats AJ, Donald PR, Hesseling AC, Schaaf HS. Tuberculosis 2016; 97: 126
• 22 Prasad MS, Bhole RP, Khedekar PB, Chikhale RV. Bioorg. Chem. 2021; 115: 105242
• 23 Li Y, Wang F, Wu L, Zhu M, He G, Chen X, Sun F, Liu Q, Wang X, Zhang W. Infect Drug Resist. 2019; 12: 721
• 24 De Vriese AS, Van Coster R, Smet J, Seneca S, Lovering A, Van Haute LL, Boelaert JR. Clinic. Infect. Dis. 2006; 42: 1111
• 25 Arbiser JL, Moschella SL. Clofazimine. J. Am. Acad. Dermatol. 1995; 32: 241
• 26 Li WR, Zhang ZQ, Liao K, Wang BB, Liu HZ, Shi QS, Xie XB. Front. Microbiol. 2022; 13: 1105921
• 27 Türe A, Kulabaş N, Dingiş S. İ, Birgül K, Bozdeveci A, Karaoğlu ŞA, Küçükgüzel İ. Bioorg. Chem. 2019; 88: 102965
• 28 Gomez C, Ponien P, Serradji N, Lamouri A, Pantel A, Capton E, Jarlier V, Anquetin G, Aubry A. Bioorg. Med. Chem. 2013; 21: 948
• 29 Parajuli NP, Mandava CS, Pavlov MY, Sanyal S. Nucleic Acids Res. 2021; 49: 6880
• 30 Lin Y, Li Y, Zhu N, Han Y, Jiang W, Wang Y, Jiang J. Antimicrob. Agents Chemother. 2014; 58: 2038
• 31 Brammachary U, Ramachandra V, Palavesam S, Kapalamurthy VR. C, Muralidhar A, Muthaiah M. Mechanisms and Action of Drug Resistance on Mycobacterium tuberculosis. In Antibiotic Resistance – New Insights. IntechOpen; London: 2022.
• 32 Vianna JF, Bezerra KS, Oliveira JI, Albuquerque EL, Fulco UL. Phys. Chem. Chem. Phys. 2019; 21: 19192
• 33 Luo M, Zhou W, Patel H, Srivastava AP, Symersky J, Bonar MM, Mueller DM. Commun. Biol. 2020; 3: 452
• 34 Van den Bossche A, Varet H, Sury A, Sismeiro O, Legendre R, Coppee JY, Ceyssens PJ. Tuberculosis 2022; 117: 18
• 35 Hegde PV, Howe MD, Zimmerman MD, Boshoff HI, Sharma S, Remache B, Aldrich CC. Eur. J. Med. Chem. 2022; 232: 114201
• 36 Tweed CD, Dawson R, Burger DA, Conradie A, Crook AM, Mendel CM, Spigelman M. Lancet Respir. Med. 2019; 7: 1048
• 37 Stephanie F, Saragih M, Tambunan US. F. Pharmaceutics 2021; 13: 592
• 38 Borah P, Deb PK, Venugopala KN, Al-Shar'i NA, Singh V, Deka S, Mailavaram RP. Curr. Top. Med. Chem. 2021; 21: 547
• 39 Dartois VA, Rubin E. J. Nat. Rev. Micro. 2022; 20: 685
• 40 Singh A, Prasad R, Balasubramanian V, Gupta N. HIV/AIDS 2020; 13: 9
• 41 Ridahunlang N, Bisht R, Rishanlang N. Infect. Disord.: Drug. Targets 2023; 23: 44
• 42 Mhiri C, Boudriga S, Askri M, Knorr M, Sriram D, Yogeeswari P, Strohmann C. Bioorg. Med. Chem. Lett. 2015; 25: 4308
• 43 Sarı Y, Akkoç S, Gök Y, Sifniotis V, Özdemir İ, Günal S, Kayser V. J. Enzyme Inhib. Med. Chem. 2016; 31: 1527
• 44 Mhiri C, Boudriga S, Askri M, Knorr M, Sriram D, Yogeeswari P, Strohmann C. Bioorg. Med. Chem. Lett. 2015; 25: 4308
• 45 Alhamzani AG, Yousef TA, Abou-Krisha MM, Raghu MS, Kumar KY, Prashanth MK, Jeon BH. Bioorg. Med. Chem. Lett. 2022; 77: 129042
• 46 Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PG. Int. J. Mycobacteriol. 2015; 4: 165
• 47 Soutter HH, Centrella P, Clark MA, Cuozzo JW, Dumelin CE, Guie MA, Read JA. Proc. Natl. Acad. Sci. U.S.A. 2016; 113: E7880
• 48 Koçak Aslan E, Han M. İ, Krishna VS, Tamhaev R, Dengiz C, Doğan ŞD, Gündüz MG. Pharmaceuticals 2022; 15: 1301
• 49 Badar AD, Sulakhe SM, Muluk MB, Rehman NN, Dixit PP, Choudhari PB, Haval KP. J. Heterocycl. Chem. 2020; 57: 3544
• 50 Patil PS, Kasare SL, Haval NB, Khedkar VM, Dixit PP, Rekha EM, Haval KP. Bioorg. Med. Chem. Lett. 2020; 30: 127434
• 51 Bhoi MN, Borad MA, Jethava DJ, Acharya PT, Pithawala EA, Patel CN, Pandya HA, Patel HD. Eur. J. Med. Chem. 2019; 177: 12
• 52 Borad MA, Jethava DJ, Bhoi MN, Patel CN, Pandya HA, Patel HD. J. Mol. Struct. 2020; 1222: 128881
• 53 Castelo-Branco FS, de Lima EC, Domingos JL. O, Pinto AC, Lourenço MC. S, Gomes KM, Costa-Lima MM, Araujo-Lima CF, Aiub CA. F, Felzenszwalb I, Costa TE. M. M, Penido C, Henriques MG, Boechat N. Eur. J. Med. Chem. 2018; 146, 529
• 54 Carrasco F, Hernández W, Chupayo O, Sheen P, Zimic M, Coronel J, Dávalos JZ. J. Chem. 2021; 1
• 55 Ghiano DG, Recio-Balsells A, Bortolotti A, Defelipe LA, Turjanski A, Morbidoni HR, Labadie GR. Eur. J. Med. Chem. 2020; 208: 112699
• 56 Dueke-Eze CU, Fasina TM, Oluwalana AE, Familoni OB, Mphalele JM, Onubuogu C. Sci. Afr. 2020; 9: e00522
• 57 Elsayed ZM, Eldehna WM, Abdel-Aziz MM, El Hassab MA, Elkaeed EB, Al-Warhi T, Mohammed ER. J. Enzyme Inhib. Med. Chem. 2021; 36: 384
• 58 Vosátka R, Krátký M, Švarcová M, Janoušek J, Stolaříková J, Madacki J, Huszár S, Mikušová K, Korduláková J, Trejtnar F, Vinšová J. Eur. J. Med. Chem. 2018; 151: 824
• 59 de Faria CF, Moreira T, Lopes P, Costa H, Krewall JR, Barton CM, Santos S, Goodwin D, Machado D, Viveiros M, Machuqueiro M, Martins F. Biomed. Pharmacother. 2021; 144: 112362
• 60 Gaonkar SL, Hakkimane SS, Bharath BR, Shenoy VP. Rasayan J. Chem. 2020; 13: 1853
• 61 Shah SR, Katariya KD. J. Heterocycl. Chem. 2020; 57: 1682
• 62 Santoso M, Fahmi MR. G, Kurniawan YS, Ersam T, Fatmawati S, Martak F, Fadlan A. Trends Sci. 2021; 18: 39
• 63 Różycka D, Korycka-Machała M, Żaczek A, Dziadek J, Gurda D, Orlicka-Płocka M, Olejniczak AB. Pharmaceuticals 2020; 13: 465
• 64 Volynets GP, Tukalo MA, Bdzhola VG, Derkach NM, Gumeniuk MI, Tarnavskiy SS, Yarmoluk SM. Future Microbiol. 2020; 15: 869
• 65 Koli BP, Gore RP, Malasane PR. Synth. Commun. 2023; 53 (18) 1506-19
• 66 Nazim U, Ali SI, Ishrat G, Hassan A, Ahmed M, Ali M, Noori MY. Pak. J. Pharm. Sci. 2020; 33: 1095
• 67 Bakale RD, Phatak PS, Rathod SS, Choudhari PB, Rekha EM, Sriram D, Haval KP. J. Biomol. Struct. Dyn. 2025; 43: 1372
• 68 Mardianingrum R, Ruswanto R, Nurjanah R, Nofianti T, Apriliani AY. J. Phys. 2019; 1: 1179
• 69 Sampiron EG, Costacurta GF, Baldin VP, Almeida AL, Ieque AL, Santos NC, Scodro RB. Future Microbiol. 2019; 14: 981
• 70 Oliveira PF, Guidetti B, Chamayou A, André-Barrès C, Madacki J, Korduláková J, Baltas M. Molecules 2017; 22: 1457
• 71 Oliveira JR, Shiguemoto CY, Neves AR. D, Moreira FM, Gomes GB, Perdomo RT, Baroni AC. J. Braz. Chem. Soc. 2020; 31: 1284
• 72 Atta A, Fahmy S, Rizk O, Sriram D, Mahran MA, Labouta IM. Bioorg. Chem. 2018; 80: 721
• 73 Rani A, Johansen MD, Roquet-Banères F, Kremer L, Awolade P, Ebenezer O, Kumar V. Bioorg. Med. Chem. Lett. 2020; 30: 127576
• 74 Kumar M, Singh K, Ngwane AH, Hamzabegovic F, Abate G, Baker B, Chibale K. Bioorg. Med. Chem. 2018; 26: 833
• 75 Patel H, Chaudhari K, Jain P, Surana S. Bioorg. Chem. 2020; 102: 104099
• 76 Kaur H, Singh L, Chibale K, Singh K. Mol. Diversity 2020; 24: 949
• 77 Dragostin I, Dragostin OM, Samal SK, Dash S, Tatia R, Dragan M, Zamfir CL. Eur. J. Pharm. Sci. 2019; 137: 104974
• 78 Pflégr V, Horváth L, Stolaříková J, Pal A, Kordulakova J, Bősze S, Krátký M. Eur. J. Med. Chem. 2021; 223: 113668
• 79 Shtyrlin NV, Khaziev RM, Shtyrlin VG, Gilyazetdinov EM, Agafonova MN, Usachev KS, Shtyrlin YG. Med. Chem. Res. 2021; 30: 952
• 80 Pflégr V, Stolaříková J, Vinšová J, Krátký M. Curr. Top. Med. Chem. 2022; 22: 2695
• 81 Rathod AS, Reddy PV, Biradar JS. Russ. J. Org. Chem. 2020; 56: 662